Vous n'êtes pas connecté
Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis Cardiol...
Covigenix VAX-002 shows significant promise as a novel DNA vaccine to stimulate immunity against circulating strains of SARS-CoV-2 in animal models...
Competitive: Fortrea: As a leading global contract research organization (CRO) with a passion for scientific rigor and decades of clinical...
Competitive: Medpace: Medpace is the leading CRO for Biotech companies and is continuing to add Clinical Trial Managers of different experience...
The power was back on ahead of schedule today for nearly 8,000 homes on the North Island, after heavy storms knocked out the entire region. From Woss...
PharmAla Biotech (CSE:MDMA) has been contracted as a supplier of MDMA to a clinical trial at Harvard’s Maclean Hospital.
InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the approval of the...
PharmaDrug (CSE: PHRX) yesterday reported that its joint venture, Sairiyo Therapeutics, has begun the process of preparing for its first clinical...